| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |